ÂÜÀòÂÒÂ×

The Advisory Team at Pinteon Therapeutics consists of a group of experts who provide strategic guidance and insights to advance the development of the novel antibody targeting toxic tau. They leverage their extensive knowledge in neurology, clinical research, and regulatory affairs to inform decision-making, optimize clinical study designs, and ensure alignment with industry standards, ultimately aiming to enhance the therapeutic impact on patients with neurodegenerative diseases.